180 related articles for article (PubMed ID: 16582616)
41. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.
Ye Y; Xiao Y; Wang W; Wang Q; Yearsley K; Wani AA; Yan Q; Gao JX; Shetuni BS; Barsky SH
Mol Cancer Res; 2009 Dec; 7(12):1984-99. PubMed ID: 19996304
[TBL] [Abstract][Full Text] [Related]
42. Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.
DelBove J; Kuwahara Y; Mora-Blanco EL; Godfrey V; Funkhouser WK; Fletcher CD; Van Dyke T; Roberts CW; Weissman BE
Mol Carcinog; 2009 Dec; 48(12):1139-48. PubMed ID: 19676100
[TBL] [Abstract][Full Text] [Related]
43. [Changes in gene expression profiles in multiple myeloma cells after knocking-down SNF5, a core subunit of SWI/SNF complex].
Xie Y; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):667-71. PubMed ID: 23688984
[TBL] [Abstract][Full Text] [Related]
44. Composition and Function of Mutant Swi/Snf Complexes.
Dutta A; Sardiu M; Gogol M; Gilmore J; Zhang D; Florens L; Abmayr SM; Washburn MP; Workman JL
Cell Rep; 2017 Feb; 18(9):2124-2134. PubMed ID: 28249159
[TBL] [Abstract][Full Text] [Related]
45. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
Darr J; Klochendler A; Isaac S; Eden A
Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
[TBL] [Abstract][Full Text] [Related]
46. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
[TBL] [Abstract][Full Text] [Related]
47. SWI/SNF complex in cancer.
Lu C; Allis CD
Nat Genet; 2017 Jan; 49(2):178-179. PubMed ID: 28138149
[TBL] [Abstract][Full Text] [Related]
48. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
49. The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.
Pancione M; Remo A; Zanella C; Sabatino L; Di Blasi A; Laudanna C; Astati L; Rocco M; Bifano D; Piacentini P; Pavan L; Purgato A; Greco F; Talamini A; Bonetti A; Ceccarelli M; Vendraminelli R; Manfrin E; Colantuoni V
J Transl Med; 2013 Nov; 11():297. PubMed ID: 24286138
[TBL] [Abstract][Full Text] [Related]
50. Generation of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.
Ng JM; Martinez D; Marsh ED; Zhang Z; Rappaport E; Santi M; Curran T
Cancer Res; 2015 Nov; 75(21):4629-39. PubMed ID: 26363008
[TBL] [Abstract][Full Text] [Related]
51. SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E.
Xu Y; Yan W; Chen X
Oncogene; 2010 Jul; 29(28):4090-100. PubMed ID: 20473326
[TBL] [Abstract][Full Text] [Related]
52. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.
Guidi CJ; Sands AT; Zambrowicz BP; Turner TK; Demers DA; Webster W; Smith TW; Imbalzano AN; Jones SN
Mol Cell Biol; 2001 May; 21(10):3598-603. PubMed ID: 11313485
[TBL] [Abstract][Full Text] [Related]
53. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
[TBL] [Abstract][Full Text] [Related]
54. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.
Lee RS; Stewart C; Carter SL; Ambrogio L; Cibulskis K; Sougnez C; Lawrence MS; Auclair D; Mora J; Golub TR; Biegel JA; Getz G; Roberts CW
J Clin Invest; 2012 Aug; 122(8):2983-8. PubMed ID: 22797305
[TBL] [Abstract][Full Text] [Related]
55. SNFing HIV transcription.
Bukrinsky M
Retrovirology; 2006 Aug; 3():49. PubMed ID: 16899112
[TBL] [Abstract][Full Text] [Related]
56. Linking the SWI/SNF complex to prostate cancer.
Lee RS; Roberts CW
Nat Genet; 2013 Nov; 45(11):1268-9. PubMed ID: 24165726
[TBL] [Abstract][Full Text] [Related]
57. Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.
Pfister NT; Fomin V; Regunath K; Zhou JY; Zhou W; Silwal-Pandit L; Freed-Pastor WA; Laptenko O; Neo SP; Bargonetti J; Hoque M; Tian B; Gunaratne J; Engebraaten O; Manley JL; Børresen-Dale AL; Neilsen PM; Prives C
Genes Dev; 2015 Jun; 29(12):1298-315. PubMed ID: 26080815
[TBL] [Abstract][Full Text] [Related]
58. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
[TBL] [Abstract][Full Text] [Related]
59. Cc.snf5, a gene encoding a putative component of the SWI/SNF chromatin remodeling complex, is essential for sexual development in the agaricomycete Coprinopsis cinerea.
Ando Y; Nakazawa T; Oka K; Nakahori K; Kamada T
Fungal Genet Biol; 2013 Jan; 50():82-9. PubMed ID: 23078835
[TBL] [Abstract][Full Text] [Related]
60. Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5.
Mora-Blanco EL; Mishina Y; Tillman EJ; Cho YJ; Thom CS; Pomeroy SL; Shao W; Roberts CW
Oncogene; 2014 Feb; 33(7):933-8. PubMed ID: 23435428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
